Last updated on February 2020

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)


Find a site near you

Start Over

Macquarie University ( Site 0151)

Macquarie University, Australia
  Connect »

Tulane Cancer Center ( Site 0066)

New Orleans, LA United States
  Connect »